Severe bradycardia after amivantamab administration in a patient with epidermal growth factor receptor-positive non-small cell lung cancer: A case report
Fujita Medical Journal · 2026-08 · 12 (3) · 251-254
DOI: 10.20407/fmj.2026-003 ↗Kurz gefasst
Fallbericht in der Zeitschrift Fujita Medical Journal, 2026-08. Verfasst von Shoko Kamenosono und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Amivantamab, a bispecific antibody targeting epidermal growth factor receptor (EGFR) and mesenchymal–epithelial transition factor, has shown clinical efficacy in patients with EGFR-mutated non-small cell lung cancer. Although infusion-related reactions (IRRs) are common adverse events associated with this drug, cardiac events such as bradycardia have rarely been reported. We report the case of a 53-year-old Japanese man with advanced EGFR exon 19-deleted lung adenocarcinoma who was treated with amivantamab plus lazertinib as eighth-line therapy. On the first day, he experienced dyspnea, chills, and headache 30 min after amivantamab administration, so the infusion flow was reduced to 25 mL/h. After the symptoms resolved, the flow rate was set to 50 mL/h. On the second day, 2 h after initiating amivantamab infusion (700 mg) at 50 mL/h, his heart rate decreased to
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Zitieren
APA
Kamenosono, S., Ikeda, A., Takahashi, H., Watanabe, T., Hase, T., Kiryu, N., Hasegawa, S., Shigeyasu, Y., Souma, T., Horiguchi, T., Goto, Y., Hashimoto, N., & Imaizumi, K. (2026). Severe bradycardia after amivantamab administration in a patient with epidermal growth factor receptor-positive non-small cell lung cancer: A case report. Fujita Medical Journal, 12(3), 251-254. https://doi.org/10.20407/fmj.2026-003
Vancouver
Kamenosono S, Ikeda A, Takahashi H, Watanabe T, Hase T, Kiryu N, et al. Severe bradycardia after amivantamab administration in a patient with epidermal growth factor receptor-positive non-small cell lung cancer: A case report. Fujita Medical Journal. 2026;12(3):251-254. doi:10.20407/fmj.2026-003
BibTeX
@article{Kamenosono2026,
author = {Kamenosono, Shoko and Ikeda, Aki and Takahashi, Hideaki and Watanabe, Toshikazu and Hase, Tetsunari and Kiryu, Nanami and Hasegawa, Shin and Shigeyasu, Yoshiko and Souma, Tomohide and Horiguchi, Tomoya and Goto, Yasuhiro and Hashimoto, Naozumi and Imaizumi, Kazuyoshi},
title = {Severe bradycardia after amivantamab administration in a patient with epidermal growth factor receptor-positive non-small cell lung cancer: A case report},
journal = {Fujita Medical Journal},
year = {2026},
volume = {12},
number = {3},
pages = {251--254},
doi = {10.20407/fmj.2026-003}
}
EUVIMED